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ABSTRACT Aptamer-based drugs represent an attractive approach in pharmacological therapy. The most studied aptamer,
thrombin binding aptamer (TBA), folds into a well-deﬁned quadruplex structure and binds to its target with good speciﬁcity and
afﬁnity. Modiﬁed aptamers with improved biophysical properties could constitute a new class of therapeutic aptamers. In this
study we show that the modiﬁed thrombin binding aptamer (mTBA), 39GGT59-59TGGTGTGGTTGG39, which also folds into a
quadruplex structure, is more stable than its unmodiﬁed counterpart and shows a higher thrombin afﬁnity. The stability of the
modiﬁed aptamer was investigated using differential scanning calorimetry, and the energetics of mTBA and TBA binding to
thrombin was characterized by means of isothermal titration calorimetry (ITC). ITC data revealed that TBA/thrombin and mTBA/
thrombin binding stoichiometry is 1:2 for both interactions. Structural models of the two complexes of thrombin with TBA and
with mTBA were also obtained and subjected to molecular dynamics simulations in explicit water. Analysis of the models led to
an improvement of the understanding of the aptamer-thrombin recognition at a molecular level.
INTRODUCTION
a-Thrombin is a serine protease with multiple functions in
homeostasis, and it is the only protein capable of catalyzing
the cleavage of ﬁbrinogen to produce ﬁbrin clot (1). The
multiple functions of a-thrombin in hemostasis concern the
procoagulant, anticoagulant, and ﬁbrinolytic pathways and
involve a large number of substrates (2). The crystallographic
structure ofa-thrombin has shown structural features explain-
ing the multiple functions of thrombin (3). Two positively
charged regions, termed exosites I and II, are present on the
enzyme surface on the opposite sides with respect to the
catalytic site. Exosite I is usually referred to as the ﬁbrinogen
recognition site and exosite II as the heparin-binding site.
The malfunctioning of thrombin results in hemorrhage,
and an excessive coagulation function results in dissemina-
tion of the clot in undamaged tissues, causing thrombosis (4).
Achieving the ability to speciﬁcally inhibit thrombin in vivo
with synthetic compounds is an important goal in the pre-
vention of thrombosis.
In 1992, Bock et al. screened a pool of;1013 synthetic oligo-
nucleotides (5) and discovered a potent inhibitor of thrombin
(6,7) based on a single-stranded 15-mer DNAwith the sequence
59GGTTGGTGTGGTTGG39 (thrombin binding aptamer, TBA).
The three-dimensional structure of TBA was solved by
NMR spectroscopy (8,9). TBA forms a unimolecular quadru-
plex in solution, arranged in a chair-like structure, consisting
of two G-quartets connected by two TT loops and a single
TGT loop. TBA does not interact with the active site of
thrombin, and a binding site was localized to the anion
exosite I (10–13). However, crystallographic studies of TBA
complex with thrombin revealed that TBA may interact
with both exosites I and II of thrombin (14,15). The three-
dimensional structures of thrombin and TBA are preserved
in the complex, and speciﬁc interactions are found involving
the exosites and the loops of the aptamer (15–17).
Recently, the TBA-based oligodeoxynucleotide 39GGT59-
59TGGTGTGGTTGG39 (modiﬁed thrombin binding aptamer,
mTBA), containing a 59-59 site of polarity inversion, was
synthesized with the aim to improve the biological and
biophysical properties of the thrombin aptamer. The mTBA
was studied by circular dichroism (CD) and NMR spectros-
copy, and its three-dimensional structure was obtained (18).
The structure presents a chair-like conformation character-
ized by an unusual folding with three strands parallel and one
strand oriented in an antiparallel manner.
In this work, we report a differential scanning calorimetric
(DSC) study of thermodynamic stability of TBA and mTBA
along with an isothermal titration calorimetric (ITC) study to
assess the binding stoichiometry and to gain information on
the energetics of binding of TBA and modiﬁed TBA to the
thrombin. To explain the different behavior of the two
aptamers we performed molecular dynamics (MD) simula-
tions of TBA and mTBA. In addition, to improve the under-
standing of the aptamer-thrombin recognition, a model of the
complexes was generated by means of docking calculations
and was subjected to MD simulations in explicit water.




The oligonucleotides were synthesized as previously reported (18). The
solutions were prepared by dissolving solid lyophilized oligonucleotides in
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the appropriate buffer and were annealed by heating to 90C for 5 min and
slow cooling to room temperature. The buffer used was 10 mM potassium
phosphate, 70 mM KCl, 0.1 mM EDTA at pH 7.0. The oligonucleotides
concentrations were determined by their adsorption measured at 90C, in the
same buffer, using the same molar extinction coefﬁcient, e(260 nm) ¼
147,300 M1cm1. The molar extinction coefﬁcient was calculated by the
nearest neighbor model, assuming that the extinction coefﬁcient of the
nucleobases involved in the inversion of the polarity site in the modiﬁed
aptamer was the same as in the DNA.
Human a-thrombin was purchased from Sigma-Aldrich (St. Louis, MO;
product number T6884) and dissolved in the same buffer used for
oligonucleotides. Protein solutions were dialyzed against the buffer solution
at 4C by using Spectra Por MW 10,000 membranes. Protein concentration
was determined spectrophotometrically using a sequence-based extinction
coefﬁcient of 66,612 M1cm1 at 280 nm.
Differential scanning calorimetry
The total heat required for the unfolding of the TBA and mTBA was
measured with a DSC from Setaram (Caluire, France; Micro-DSC III)
interfaced with a personal computer. Linear baselines were drawn for each
scan, and molar heat capacity values were generated when the molecular
weights of the molecules and the molar concentrations used during each scan
were introduced. Since DHocal ¼
R
DCpðTÞdT; the area of each peak yields a
corresponding transition enthalpy, and the peak maximum yields the
transition melting temperature. Given DSocal ¼
R ðDCpðTÞ=TÞdT the calori-
metric peak was plotted as DCp/T versus T to yield a curve, the area of which
is DS. The enthalpy and entropy determinations allowed the calculation of
the Gibbs free energy via the equation DGo298K ¼ DHocal  TDSocal:All values
reported are an average of at least three repeated measurements.
Two cells, the sample cell containing 800 mL of TBA or mTBA solution
and the reference cell ﬁlled with the same volume of buffer solution, were
heated from 10C to 95C at three different heating rates (0.3, 0.5, and
1.0C min1). The molecules concentration range was from 8.9 3 104 to
1.1 3 103 M. This ramp rate over this temperature range led to no
hysteresis and thus the complete reversibility of each scan.
Isothermal titration calorimetry
The binding energetics of both TBA and mTBA to thrombin was obtained
with a CSC 4200 Calorimeter from Calorimetry Science (Lindon, Utah) at
25C. Titration experiments were done with successive injections of
thrombin into the sample cell (1300 mL) containing 1.6 mM TBA or mTBA
until saturation was achieved. Titrations were carried out using a 250 mL
syringe with stirring at 297 rpm. The solutions of thrombin and DNA
samples were prepared in the same buffer. Control experiments were done
by injecting thrombin in buffer to obtain the heat effects for dilution of the
protein. The calorimetric enthalpy for each injection was calculated after
correction for the heat of thrombin dilution. To obtain the thermodynamic
properties of interactions, a nonlinear regression analysis was performed
using a single set of identical independent binding sites.
Molecular dynamics simulations
All simulations were performed by means of the GROMACS package (19),
employing the all-atom force ﬁeld parm98 (20). The initial structures of
TBA and mTBA were generated by using the coordinates of the NMR
structures (TBA Protein Data Bank code: 148D, mTBA Protein Data Bank
code: 2IDN), computing the average structure over the 12 and 7 NMR
structures, respectively. The mTBA nonstandard residue was created using
the Xleap module of the AMBER 7.0 package (21). The molecules were
neutralized with 14 Na1 ions (placed following electrostatic potential
values) and solvated in a cubic box of size 60 3 60 3 60 A˚3 containing
;6950 TIP3P water molecules (22). Initially, water molecules and ions were
relaxed by a ﬁrst steepest descent energy minimization with positional
restraints on solute. The LINCS algorithm (23) was used to constrain the
bonds and to carry out an initial simulation, 200 ps long, with the positions
of the solute atoms restrained by a force constant of 3000 kJ mol1nm2 to
let water molecules diffuse around the complex and to equilibrate. Simu-
lations were carried out with periodic boundary conditions at a constant
temperature of 300 K. The Berendsen algorithm was applied for temperature
and pressure coupling (24), and the particle mesh Ewald method (25) was
used for the calculation of electrostatic contribution to nonbonded inter-
actions (grid spacing of 0.12 nm). The trajectory length was 5 ns long for
each system.
Docking, complex selection, and simulations
To obtain a model of the complex of TBA with two thrombin molecules,
rigid-body docking calculations were carried out by using the program
ZDOCK 2.3 (26,27). The structure of the 1:1 complex between the NMR
model of TBA and thrombin (hereafter referred to as thrombin A) was kept
ﬁxed and, using the TBA molecule as target, a second molecule of thrombin
(hereafter referred to as thrombin B) was allowed to rotate and translate
around the target. We generated 2000 docked structures, starting from
randomly chosen relative orientations. Favorable complexes were selected
by a restraint ﬁltering chosen on the basis of the contacts indicated by x-ray
data. For TBA the OP atoms of residues G2, G5, T7, and T9 were identiﬁed
by x-ray to be in contact with the N atoms of the side chains of Arg-233, Lys-
236, Lys-240, and Arg-93 of a second thrombin (the residue numeration is
according to x-ray structure (15)). An OP-N (TBA-thrombin B) distance
below a cutoff of 6 A˚ was counted as a restraint satisfaction. These restraints
were sufﬁcient for an unambiguous complex selection. Indeed, only one of
the 2000 docked complexes was passing the ﬁlter and presented the
thrombin B in a suitable position for binding. This complex was used as the
starting structure of MD simulations.
Since structural data concerning the complex were not available in the
case of the modiﬁed aptamer, to obtain a reasonable starting model of the
complex of mTBA with two thrombin proteins the structure of the complex
with TBA, obtained by docking, was chosen as a template. The backbone of
mTBA was superimposed onto that of TBA complexed with thrombin
molecules. The resulting mTBA-thrombin complex model was then energy
minimized in vacuo by 1000 steps of the steepest descent method.
The minimizations and successive MD simulations in explicit water were
carried out with the protocol described above. The two complexes,
consisting of 9232 protein atoms and 488 nucleic acid atoms, were solvated
in a box of size 85 3 80 3 115 A˚3 containing ;22,900 TIP3P water
molecules. To neutralize the system, six water molecules were replaced by
Na1 ions (placed following electrostatic potential values). The trajectory
length was 2 ns long for each complex.
RESULTS
DSC melting study
We investigated the unfolding of TBA and mTBA using
differential scanning microcalorimetry. The DSC melting
curves for the two quadruplexes are shown in Fig. 1, and the
corresponding thermodynamic parameters are listed in Table
1. In the experimental conditions, the transitions of TBA and
mTBA are reversible, as demonstrated by the recovery of the
original signal by rescanning the same sample. Furthermore,
the change of the heating rate from 0.3C to 1.0C min1
does not alter the thermodynamic parameters signiﬁcantly,
thereby demonstrating that the studied processes are not
kinetically controlled.
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The DSC curve of TBA shows a symmetric shape with a
maximum centered at 53C. The integration of the denatur-
ation peak gives a DH(Tm) of 96 kJ mol1. The calorimetric
curve of mTBA also shows a symmetric transition and
exhibits both higher Tm ¼ 58C and DH(Tm) ¼ 146 kJ
mol1. The calculated DG(298) values are 8 kJ mol1 and
17 kJ mol1 for TBA and mTBA, respectively.
The thermodynamic parameters were calculated assuming
a negligible difference in the heat capacity between the initial
and ﬁnal states because, for the investigated transitions, the
two states showed comparable heat capacity values. The
melting temperatures are in good agreement with those
previously obtained by CDmelting proﬁles (18), whereas the
enthalpy values are lower than those derived from the van ’t
Hoff analysis of CD curves, even if the van ’t Hoff enthalpy
calculated for mTBA by DSC curves (163 kJ mol1) is in
good agreement with the experimental value directly
obtained by the area under the curves. For the TBA,
analogous thermodynamic parameters were also reported by
Macaya et al. (8) and recently by Olsen et al. (28) in a
calorimetric study of quadruplexes. The latter authors
thought the discrepancy between calorimetric and van ’t
Hoff enthalpy values was due to aggregation phenomena. On
the other hand, a few years ago, to obtain a calorimetric
enthalpy value in agreement with the van ’t Hoff enthalpy
value, Smirnov and Shafer (29) analyzed the TBA calori-
metric data, taking into account temperature-dependent heat
capacities that vary linearly with T.
The whole set of thermodynamic parameters shows that
the mTBA is more stable than its unmodiﬁed counterpart.
The enthalpy value for mTBA is 50 kJ mol1 higher. This
result suggests the presence of additional intramolecular
interactions. Further, entropy change values suggest that the
modiﬁed aptamer possesses a more rigid structure with
respect to TBA.
ITC study
To study the thermodynamics of the interaction of TBA and
mTBA with thrombin, we performed ITC experiments. In
the upper panels of Fig. 2 are shown the results of the
calorimetric titrations of the aptamers into buffered thrombin
solution, conducted at 25C. In both cases, an exothermic
heat pulse is observed after each injection of protein solution
into the aptamer solution. The area of each exothermic peak
is integrated and the obtained heat is divided by the moles of
thrombin injected. The binding data were corrected for the
dilution heats associated with the addition of the thrombin
into buffer, separately determined by injection of either throm-
bin solution into buffer. The resulting values are plotted as a
function of the molar ratio to give the corresponding binding
isotherms shown in the lower panels.
The corrected data were ﬁtted using the more simplistic
model that assumes a single set of equivalent binding sites to
determine the stoichiometry (n), binding constant (Kb), and
binding enthalpy (DbH). The stoichiometry of both com-
plexes clearly indicates that in solution two thrombin mole-
cules bind to one DNA aptamer. Because the two binding
modes do not have distinct energetic proﬁles, the application
of a two-independent-sites model to ﬁt the titration data
provides poorer results. The single set of the equivalent sites
model is the simplest model to derive K and DbH. These
thermodynamic parameters are averaged on all the micro-
state values. The binding Gibbs energy change, DbG, and
entropy change, DbS, are calculated from the equations
DbG ¼ RT lnKb and TDbS ¼ DbH  DbG. The thermo-
dynamic parameters are collected in Table 2.
The values of the binding constants and the Gibbs energy
changes indicate that the associations are strongly favored, at
25C, from a thermodynamic point of view. The investigated
aptamers bind to thrombin with different afﬁnity. Indeed, the
equilibrium constant for the interaction of mTBA with
thrombin (Kb ¼ 4 3 107 M1) is about one order of
magnitude greater than that for the TBA-thrombin interac-
tion (Kb¼ 33 106 M1). The values of DbH and DbS show
that, in both cases, the binding processes are enthalpically
driven; however, the interaction of mTBA with thrombin is
associated with a larger favorable enthalpy (DbH¼160 kJ
mol1) as compared to TBA (DbH ¼ 110 kJ mol1).
Our results reinforce x-ray data, resolving any doubts
about the stoichiometry, and indicate that the interaction of
the aptamer with two thrombin molecules is not unique to the
crystal complex.
FIGURE 1 DSC proﬁles for TBA (dashed line) and mTBA (solid line) at
1C/min. The experiments were performed in a 10 mM potassium phosphate
buffer (pH 7.0) supplemented with 70 mM KCl.








TBA 53.0 6 0.5 96 6 5 0.30 6 0.02 8 6 1
mTBA 57.9 6 0.5 146 6 5 0.43 6 0.02 17 6 1
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Molecular dynamics of TBA and mTBA
MD simulations of the two aptamers produce stable trajec-
tories, as shown by macroscopic properties of the systems
such as density, potential, and total energies (data not
shown). The time evolution of the root mean-square
deviation (RMSD) values, with respect to the initial energy
minimized structure, was calculated for all the atoms in the
TBA and mTBA quadruplexes as well as for the guanine
base atoms of tetrads (see Fig. 3). It is observed that the all-
atoms RMSD gradually increases during the ﬁrst 1 ns of
simulations and then ﬂuctuate around an average value of 2.1
A˚ for the TBA and 2.4 A˚ for the mTBA during the last 4 ns.
Interestingly, the RMSD of the guanine bases of tetrads
oscillates around an average value of 0.6 A˚ for the TBA and
0.8 A˚ for the mTBA, indicating that, in both cases, the
G-tetrads are rigid and very stable during the entire simulation.
Stereo diagrams of average structures, over the last 4 ns of
MD simulations, are shown in Fig. 4. The resulting structures
are in good agreement with the NMR structures used as a
starting model. In particular, the unusual characteristics of
the mTBA, like the anti-anti-anti-syn and syn-syn-syn-anti
arrangements of the two tetrads, as well as the peculiar
groove widths, are maintained in the theoretical structure.
Helix parameters of the two average structures were
calculated with the program CURVES (30) (see Supple-
mentary Material). A comparison between the parameters of
TBA and mTBA indicates that the base stacking is more
efﬁcient in the latter. Indeed, Buckle and Stagger values
suggest that the bases within the tetrads of mTBA are more
coplanar; and the Rise and Tilt values indicates that the
tetrads of mTBA are more parallel to each other in
comparison with the tetrads of TBA.
Visual inspection of the trajectories clearly shows that the
main differences between the two aptamers concern the
behavior of loops bases. This different behavior is well
FIGURE 2 (Top) Raw calorimetric
data for titration of TBA (on the left)
and mTBA (on the right) with serial
injections of different volumes of throm-
bin solution. (Bottom) Binding isotherms
resulting from integration of raw calori-
metric data after correction for the heat
of thrombin dilution.











TBA 1.8 6 0.1 (3 6 1) 3 106 110 6 9 0.24 6 0.03 37 6 1
mTBA 1.9 6 0.1 (4 6 1) 3 107 160 6 7 0.39 6 0.02 43 6 1
FIGURE 3 Time dependence of RMSD for all the atoms (top plots) and
for the guanine base atoms of tetrads (bottom plots) of TBA (black) and
mTBA (shaded) during the MD simulations.
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emphasized in Fig. 5, where the difference between TBA and
mTBA atomic ﬂuctuations (DRMSF) is reported. The largest
differences in root mean-square ﬂuctuations (RMSF) are
associated with the bases T3 (atoms 77–90), T7 (atoms 207–
209), and T9 (atoms 272–285) of TBA. The smaller
ﬂuctuations of T3 of mTBA in comparison to T3 of TBA
could be ascribed to the diverse base orientation that could
confer less mobility. Analysis of the trajectory reveals that
the T7 of mTBA, which folds back into a groove, forms long
time-residence intramolecular H-bonds with the guanine
bases of the tetrads. In particular, three H-bonds were
observed: O2(T7)N2(G6), O4(T7)N2(G11), and
N3(T7)N3(G11), with an H-bond distance of ,3.4 A˚ for
more than 80% of the simulated time for the ﬁrst one and
more than 50% for the last two. These interactions are not
present in the TBA. Visual inspection of the MD simulation
also reveals that the T9 of mTBA remains coplanar and
parallel to the adjacent G-tetrad, maintaining the stacking
interactions during the entire simulation, whereas the T9 of
TBA ﬂuctuates toward the solvent.
Docking and MD simulations of complexes
We performed ZDOCK calculations with the thrombin
molecule and the 1:1 TBA-thrombin complex solved by
x-ray. One of the 2000 docked complexes satisﬁed the ﬁlter
and presented the thrombin in a suitable binding position
(see Materials and Methods). For this complex, 2 ns of MD
simulations were performed, and the ﬁnal structure was used
for further analysis. The resulting model of the 2:1 thrombin-
TBA complex is reported in Fig. 6 A. The time evolution of
the RMSD values with respect to the starting structures
indicates that the molecular components of the complex have
individually reached stable structures during the 2 ns long
simulation (Fig. 7 A). Table 3 shows the interactions between
TBA and the exosites I and II of thrombin A and thrombin
B, respectively. During the MD simulations a large number
of contacts are conserved and additional interactions are
formed. In particular, the hydrophobic interactions between
T3 and Tyr-76 and those between T12 and the residues Ile-
24, His-71, Ile-79, and Tyr-117, indicated by Padmanabhan
and Tulinsky (15), remain unaltered. In contrast, the more
weak interaction between T3 and Ile-82 is lost. Visual
inspection of the complex reveals that additional interactions
concerning the exosite I of thrombin A and the nucleotides of
the TT loops of TBA are present: a), the side chain of Arg-67
forms an ion pair with O2P atom of T4; b), the NE and NH2
atoms of Arg-75 make two hydrogen bonds with O2 of T4
and O4 of T13, respectively; c), the side chain of Glu-77
forms a hydrogen bond with the nitrogen atom of T12; d), the
side chain of Arg-77A forms a hydrogen bond with O2 of
T13; and e), the NH2 group of Asn-78 forms a hydrogen bond
FIGURE 4 Stereo view representation of the average
structures over the last 4 ns of MD simulations of TBA
(top) and mTBA (bottom).
FIGURE 5 Difference between the atomic ﬂuctuations of TBA and
mTBA. The largest differences in RMSF (DRMSF) are associated with the
atoms 77–90 (T3 base), atoms 207–209 (T7 base), and atoms 272–285 (T9
base) of TBA.
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with the phosphate oxygen atom of T13. It is worth noting
that His-71, Arg-75, Tyr-76, and Arg-77A were reported to
be important for inhibition by the thrombin aptamer (10,12).
Exosite II of thrombin B, as also suggested by
Padmanabhan and Tulinsky (15), interacts through numer-
ous ion pairs and hydrogen bonds with TBA residues. In the
starting structure, the side chain of Arg-233 forms an ion pair
with the O2P atom of G2. During the simulation this contact
is lost and the O1P atom of G2 gains interaction with the side
chain of Lys-236, which, at the same time, forms another ion
pair with the O1P atom of G5. The side chains of Lys-240
and Arg-93 form good ion pairs with the O1P atoms of T7
and T9, respectively. These contacts persist for the entire
simulation.
MD simulations of the complex of mTBA with two throm-
bin molecules also produced stable trajectories as shown
by RMSD of the components of the complex (Fig. 7 B). The
structural model of the 2:1 thrombin-mTBA complex is
reported in Fig. 6 B. The contacts between mTBA and the
exosites of the two proteins are reported in Table 3. The
comparison between the patterns obtained for the complex
with TBA and the complex with mTBA indicates that, even
though some contacts are conserved, several differences
occur. In particular, for the exosite I of thrombin A, residues
Ile-24, Arg-75, Tyr-76, and Ile-79 make similar interactions
with mTBA. On the other hand, the interactions with the
side chains of residues His-71, Glu-77, and Tyr-117 are lost
in the complex with mTBA. Residues Arg-67, Arg-77A, and
FIGURE 6 Structural models of the complex of (A) TBA or (B) mTBA
with two thrombin molecules. The interacting residues of exosite I (green)
and exosite II (cyan) are shown.
FIGURE 7 Time evolution of RMSD for DNA (black lines), thrombin A
(shaded lines), and thrombin B (light shaded lines) of the complex with TBA
(A) and the complex with mTBA (B).
TABLE 3 Interactions between thrombin and aptamers
TBA
DNA Thrombin A Interaction
T3 Tyr-76 Hydrophobic
T4 O2P Arg-67 NH1 Ion pair





T12 N3 Glu-77 OE2 Hydrogen bond
T13 O4 Arg-75 NH2 Hydrogen bond
T13 O2 Arg-77A NH2 Hydrogen bond
T13 O2P Asn-78 ND2 Hydrogen bond
DNA Thrombin B Interaction
G2 O1P Lys-236 NZ Ion pair
G5 O1P Lys-236 NZ Ion pair
T7 O1P Lys-240 NZ Ion pair
T9 O1P Arg-93 NH1 Ion pair
mTBA
DNA Thrombin A Interaction
T3 Tyr-76 Hydrophobic
T3 O4 Arg-67 NH2 Hydrogen bond
T4 O2 Arg-75 NE Hydrogen bond
T4 O4 Arg-77A NE Hydrogen bond
T12 Ile-24 Hydrophobic
T12 Ile-79 Hydrophobic
T12 O2 Asn-78 ND2 Hydrogen bond
T13 O4 Arg-75 NH2 Hydrogen bond
DNA Thrombin B Interaction
G2 O2P Arg-233 NE Ion pair
G2 O2P Arg-233 NH2 Ion pair
T4 O1P Lys-236 NZ Ion pair
G5 O1P Lys-236 NZ Ion pair
G6 O1P Lys-240 NZ Ion pair
T9 O1P Arg-93 NH1 Ion pair
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Asn-78 interact with the modiﬁed aptamer but in a different
manner. Indeed, the side chain of Arg-67 forms a hydrogen
bond with the T3 base, the side chain of Arg-77A forms a
hydrogen bond with O4 of T4, and the NH2 group of Asn-78
forms a hydrogen bond with the O2 atom of T12. It is worth
noting that Arg-75, identiﬁed as a key determinant for
interaction with TBA (10,13), makes two identical hydrogen
bonds in both models.
Differences also occur in the case of exosite II of thrombin
B. Although Arg-93 interacts with mTBA in the same
manner as with TBA, Lys-236 and Lys-240 have a different
behavior. Indeed, the side chain of Lys-236 makes, simul-
taneously, two ion pairs with O1P atoms of T4 and G5; and
Lys-240 forms an ion pair with the O1P atom of G6. In
addition, the side chain of Arg-233 makes two hydrogen
bonds with phosphate oxygen atoms of G2. These interac-
tions are not present in the complex with TBA.
DISCUSSION
We investigated the thermodynamic stability of TBA and
mTBA by DSC and the energetics of binding of these
molecules to thrombin by ITC. DSC data indicate that
mTBA is more stable than TBA. Inspection of Table
1 reveals that the introduction of a 59-59 inversion of polarity
increases the melting temperature of ;5C. The Tm trend
reﬂects the thermodynamic stability as shown by the Gibbs
energy values. The enthalpy value for the unmodiﬁed
aptamer is in agreement with the values previously reported
for the same molecule (8,28). The DH(Tm) value for the
mTBA is 50 kJ mol1 higher than TBA. These results
suggest the presence of additional intramolecular interac-
tions in the modiﬁed aptamer. Moreover, the entropy change
values suggest that mTBA possesses a more rigid structure
with respect to TBA. These ﬁndings can be rationalized by
the results of MD simulations: a), in the mTBA the T7 forms
intramolecular hydrogen bonds with the guanine bases of the
tetrads that are entirely lost in TBA; b), mTBA presents
stronger stacking interactions between the G-tetrads as
compared to TBA; and c), the T9 base of mTBA, differently
from TBA, remains perfectly stacked with the adjacent
G-tetrad during the entire simulation. These supplementary
interactions of the thymine bases and the strong stacking
interactions of the neighboring guanine tetrads may justify
the higher enthalpy change observed for the denaturation of
mTBA in comparison with TBA. Moreover, the bases T3,
T7, and T9 of TBA show larger ﬂuctuations than those of
mTBA. The lower mobility of the bases of mTBA loops, in
comparison to TBA, suggests that the modiﬁed aptamer
possesses a more rigid structure with a lower entropy. This
could justify the major entropic gain observed for the
denaturation process of this molecule.
ITC measurements demonstrate that the binding of TBA
and mTBA to thrombin is exothermic in nature and that both
aptamers bind with a stoichiometry of 1:2 (aptamer/protein).
The latter ﬁnding is consistent with the crystallographic
studies of the TBA complex with thrombin that revealed that
TBA was sandwiched between two thrombin molecules,
contacting exosite I on one thrombin molecule and exosite II
on the other.
ITC data do not permit a distinction between the two sites
because the titration data do not have distinct energetic
proﬁles; however, the thermodynamic data reveal that
mTBA has, on average, a higher afﬁnity for thrombin and
that its interaction is associated with a larger favorable
enthalpy change (Table 2). The ranking orders of binding
constants and enthalpies found in this calorimetric study are
not in agreement with the biological activity previously
measured in vitro where TBA showed a more marked effect
over mTBA (18). Moreover, Tsiang et al. (12), studying the
ability of TBA to inhibit mutant thrombins, have proposed
that TBA does not bind to exosite II or that exosite II binding
is noninhibitory. Wang et al. (17) additionally showed that
the substitution of an abasic residue for either T4 or T13
bases signiﬁcantly reduces the inhibition of thrombin. In our
structural models, both T4 and T13 bases form hydrogen
bonds with residues of exosite I.
The overall picture that emerged from this thermodynamic
analysis, also taking into account the ﬁndings of other
research groups and our MD simulations results, is that the
aptamers interact with both exosites I and II and that the
binding to exosite I is the only one with an inhibitory effect.
This could justify not only the binding stoichiometry but also
the disagreement between thermodynamic results and bio-
logical activity. In fact, mTBA binds to thrombin with an
increased afﬁnity, but this enhancement could be due to
better interaction with the not-inhibiting exosite II.
MD simulations of complexes, which allow an analysis of
the binding mode at the molecular level, corroborate this
hypothesis. Indeed, the molecular models show that the
residues of exosite I make more contacts with TBA than
mTBA, and, conversely, the residues of exosite II make more
interactions with the modiﬁed aptamer (see Table 3).
Although mTBA forms less and different interactions with
the exosite I of thrombin A, it is interesting to note that the
interaction mode of Arg-75, identiﬁed as fundamental for
aptamer binding and inhibition, is also preserved in this case.
Other four residues were identiﬁed by mutagenesis studies
(12) as being important for inhibition by a thrombin aptamer:
Lys-70, His-71, Tyr-76, and Arg-77A. In our models, Tyr-76
forms the same electrostatic interaction in both complexes,
whereas Arg-77A interacts with the modiﬁed aptamer in a
different manner, and His-71 does not interact with mTBA.
These two differences could explain the decreasing of
inhibitory activity. It is also interesting to emphasize that,
in both models, the side chain of Lys-70 does not interact
with the aptamers but is involved in interactions with other
amino acids of exosite I. In particular, Lys-70 forms a
hydrogen bond with the backbone oxygen atom of Arg-75
and two ion pairs with side chains of Glu-77 and Glu-80 (see
568 Pagano et al.
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Supplementary Material). A mutation of Lys-70 breaks these
interactions, allowing the negatively charged side chains of
Glu-77 and Glu-80 to move, preventing the binding of the
aptamer.
In conclusion, the stability of TBA and of a modiﬁed TBA
containing an inversion of polarity and the binding energet-
ics of these molecules to thrombin were investigated
experimentally. MD simulation studies of the aptamers
provided information about the different stability behavior of
the molecules and the structural models of complexes with
thrombin molecules provided a detailed view of the inter-
actions occurring between each aptamer and its target.
Biophysical studies presented here show that a ﬁne analysis
of the molecular recognition process is fundamental for a
rational aptamer design.
SUPPLEMENTARY MATERIAL
To view all of the supplemental ﬁles associated with this
article, visit www.biophysj.org.
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